Search the Newsreel

Nano Dimension reshapes board under Murchinson agreement

Nano Dimension has announced a significant board and leadership restructuring following a settlement agreement with shareholder Murchinson Ltd., which led to the cancellation of an upcoming EGM. The agreement results in the resignation of four directors and the appointment of three Murchinson nominees, with …

Expensify sets Aug. 6 call to discuss second-quarter results

Ensign Group (ENSG) Pulls Back As Investors Question Whether Its Premium Valuation Still Fits

Nano Dimension (NNDM) Proxy filing Summary

Nano Dimension (NNDM) has scheduled an Extraordinary General Meeting for July 31, 2026, to address proposals affecting governance and board composition, initiated by a shareholder demand. Shareholders of record as of June 23, 2026, can vote on proposals including the continuation of a strategic …

Form 4 The Ensign Group Inc For: 22 July By Investing.com

This article reports on the filing of Form 4 by The Ensign Group Inc. on July 22. Form 4 filings are legally required documents that register changes in beneficial ownership of securities by a company's officers, directors, or any person who owns more than …

Ensign Group, Inc. (ENSG) director sells 392 shares under plan

John O. Agwunobi, a director at Ensign Group, Inc. (ENSG), sold 392 shares of common stock for $171.06 per share on July 20, 2026. This transaction was executed under a Rule 10b5-1 trading plan adopted on July 31, 2025. Following the sale, Agwunobi directly …

Nano Dimension Ltd. (NASDAQ: NNDM) sees Oramed stake drop to 3.3%

Oramed Pharmaceuticals Inc. has reduced its beneficial ownership in Nano Dimension Ltd. (NASDAQ: NNDM) to 3.3%, now holding 6,879,708 shares. This reduction followed a block sale of 8,200,000 Nano Dimension shares on July 20, 2026, at $1.55 per share, alongside various options trades. Oramed …

The Ensign Group, Inc. (ENSG) Stock Price, News, Quote & History

This Yahoo Finance page provides comprehensive financial data for The Ensign Group, Inc. (ENSG), including its stock price, historical performance, key statistics, and company overview. It details the company's segments and services in skilled nursing and senior living, along with analyst insights and comparison …

Director John Agwunobi Sells Shares of Ensign Group Inc

Director John Agwunobi of Ensign Group Inc (ENSG) sold 392 shares on July 20, 2026, reducing his total holdings to 9,503.149 shares. Over the past year, Agwunobi has sold 1,176 shares with no purchases, and the company has seen 32 insider sells and no …

PensionBee Group Q2 Earnings Call Highlights

Key Points Interested in PensionBee Group plc? Here are five stocks we like better. Q2 showed strong growth for PensionBee, with assets under administration rising 37% year over year to £8.6 billion and annual run-rate revenue up 40% to £56 million. Quarterly net flows …

Intensity Therapeutics grants 5,500-share option to director | INTS Insider Trading

Intensity Therapeutics (INTS) director Donovan Daniel received a stock option grant for 5,500 shares of common stock on July 16, 2026. The option has an exercise price of $4.90 per share, expires on July 16, 2036, and vests in four equal annual installments beginning …

Ensign Group Remains Attractive on Strong Skilled-Nursing Trends, Oppenheimer Says

Oppenheimer has reiterated its Outperform rating on Ensign Group (ENSG) and maintained a price target of $135, citing strong demand for skilled nursing, favorable reimbursement trends, and a successful acquisition strategy. The firm believes Ensign is well-positioned for further growth, with strong financial performance …

Ensign Group earnings on deck: Growth targets meet staffing scrutiny By Investing.com

The Ensign Group Inc. is set to announce its second-quarter results, with analysts anticipating continued growth despite recent scrutiny over staffing practices. Investors will be focusing on the company's ability to sustain margins amid rapid expansion and address concerns raised by a short-seller report. …

Ensign Group director Agwunobi disposes of $67,055 in stock

John O. Agwunobi, a director at The Ensign Group, Inc. (NASDAQ:ENSG), sold 392 shares of company stock for $67,055 on July 20, 2026, as part of a Rule 10b5-1 trading plan. Despite this sale and recent short-seller allegations regarding compliance and patient care, RBC …

Intensity Therapeutics (INTS) Proxy filing Summary

Intensity Therapeutics (INTS) has released a proxy filing summary for its upcoming virtual annual meeting on June 16, 2026. Shareholders as of April 23, 2026, will vote on proposals including the election of two directors, ratification of the auditor, and amendments to equity plans. …

Intensity Therapeutics (INTS) Q1 2026 earnings summary

Intensity Therapeutics (INTS) reported a Q1 2026 net loss of $2.4 million, an improvement from Q1 2025, primarily due to reduced R&D expenses. The company ended the quarter with $10.2 million in cash, supported by recent fundraising and a new ATM facility, but faces …

Bragar Eagel & Squire, P.C. is Investigating The Ensign Group, Inc. on Behalf of Ensign Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating The Ensign Group, Inc. after a short report alleged the company's business model relies on inadequate patient care and gaming quality metrics, leading to understaffing and patient harm. Following the report's publication, Ensign Group's stock price fell …

Nano Dimension (NNDM) Appoints New Interim CEO and Chairman

Nano Dimension (NNDM) announced the appointment of Moshe Rozenbaum as interim CEO and Phillip Borenstein as chairman of the board, effective immediately. These leadership changes are aimed at navigating strategic initiatives and enhancing operational effectiveness. The company, operating in hardware solutions for advanced manufacturing, …

Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board

Nano Dimension Ltd. has announced the appointment of Moshe Rozenbaum as Interim Chief Executive Officer, effective immediately. Additionally, Phillip Borenstein has been appointed as Chairman of the Board. These appointments aim to ensure business continuity and evaluate strategic priorities to maximize shareholder value during …

Kaplan Fox is Investigating The Ensign Group, Inc. (NASDAQ: ENSG) for Potential Securities Law Violations - Investors Encouraged to Contact the Firm

Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations by The Ensign Group, Inc. (NASDAQ: ENSG) following a report by Hunterbrook Media titled “Ensign: The Nursing Home Empire Built On Fatal Neglect.” The report alleges that Ensign provides inadequate care and manipulates …

Nano Dimension Ltd. SEC Filing (Jul 21, 2026)

Nano Dimension Ltd. announced a settlement agreement with Murchinson Ltd., leading to the withdrawal of Murchinson's proxy solicitation and the cancellation of an extraordinary general meeting. As part of the agreement, four directors resigned from Nano Dimension's board, and three new directors were appointed. …

Form 13D/A Nano Dimension Ltd. For: 21 July By Investing.com

This article from Investing.com announces the filing of Form 13D/A for Nano Dimension Ltd. on July 21. The content primarily lists various market data, financial instruments, and popular articles, with the core subject being the SEC filing. The article provides no further details beyond …

Nano Dimension Taps Interim CEO as Board Reviews Priorities

Ensign Energy Services (TSE:ESI) Stock Price Crosses Above 200-Day Moving Average - Here's Why

Ensign Energy Services Inc. - Second Quarter 2026 Earnings Conference Call and Webcast

Nano Dimension (NNDM) investors report 8.1% stake and board settlement

Murchinson Ltd. and affiliated entities reported an updated beneficial ownership of 8.1% in Nano Dimension Ltd. after agreeing to a settlement. This agreement led to the resignation of four directors and the appointment of three new directors, and the withdrawal of the investors' demand …

Intensity Therapeutics (INTS) director awarded 5,500 stock options at $4.90

Intensity Therapeutics, Inc. (INTS) director Emer Leahy was granted 5,500 stock options at an exercise price of $4.90 per share. These options will vest in four equal annual installments starting July 16, 2026, and will expire on July 16, 2036. This transaction reflects equity …

Intensity Therapeutics (INTS) awards CFO 34,000 stock options at $4.90

Intensity Therapeutics has granted its Chief Financial Officer, Joseph Talamo, 34,000 stock options with an exercise price of $4.90 per share. These options, which expire on July 16, 2036, will vest in four equal annual installments starting July 16, 2027, contingent on his continued …

Nano Dimension (NNDM) Restructures Board Following Investor Agreement

Nano Dimension (NNDM) has restructured its board effective July 20, 2026, following an agreement with activist investor Murchison, which owns 7.4% of the company. CEO Dave Stehlin, board chairman Robert Pons, and directors Joshua Rosensweig and Andrew Sriubas have stepped down, replaced by Moshe …

Kaplan Fox Alerts The Ensign Group, Inc. (ENSG) Investors to an Investigation of Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. (ENSG) following a report by Hunterbrook Media alleging inadequate care and systematic misrepresentations. The report, titled "Ensign: The Nursing Home Empire Built On Fatal Neglect," caused Ensign's stock price …

Ensign Group (ENSG) insider Agwunobi plans 392-share NASDAQ stock sale

Ensign Group insider John O. Agwunobi has filed a notice to sell 392 common shares of ENSG stock through Fidelity Brokerage Services LLC on NASDAQ on July 20, 2026, with an estimated value of $67,055.52. The filing also detailed restricted stock vesting events totaling …

Four Nano Dimension directors resign; Murchinson nominees join board

Nano Dimension and Murchinson Ltd. have reached a settlement agreement, leading to the cancellation of Nano Dimension's July 31, 2026, Extraordinary General Meeting. Under the terms of the agreement, four incumbent directors resigned, and three Murchinson-nominated directors were appointed to Nano Dimension's board. This …

Press Release: Nano Dimension and Murchinson Announce Agreement to Reconstitute the Company's Board of Directors

Nano Dimension and Murchinson Ltd. have reached an agreement to reconstitute Nano Dimension's Board of Directors. The agreement includes the immediate appointment of two new independent directors proposed by Murchinson and a third independent director to be appointed mutually within 45 days. This resolution …

Sensient Technologies (SXT) Q2 2026 Preview: EPS Est. $1.03, Reports July 24

Sensient Technologies (SXT) is expected to report Q2 2026 earnings of $1.03 per share on revenue of $448.9 million, representing significant year-over-year growth. While analyst EPS estimates have seen a slight downward revision in the last 30 days, they are up over the 90-day …

Nano Dimension and activist investor Murchison complete overhaul to board; CEO exits

Nano Dimension and activist investor Murchison have reached an agreement to overhaul Nano's board of directors and the CEO position, leading to the departure of CEO Dave Stehlin and several directors. This move is aimed at aligning the company's strategy with shareholder interests and …

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Leader Offering 27% Potential Upside

The Ensign Group, Inc. (ENSG) is a prominent healthcare provider with a $10.01 billion market cap, specializing in skilled nursing, senior living, and rehabilitative services. Analysts project a potential upside of 27.16% for ENSG, with an average target price of $217.80, driven by strong …